Sartorius AG ST Stock

Price

Target price

/ Tradegate WKN: 716560 / Symbol: SARTF / Name: Sartorius / Stock / Healthcare Equipment & Supplies / Mid Cap /

Latest predictions

buy

Your prediction

Sartorius AG ST Stock

Heavy losses for Sartorius AG ST today as the stock fell by -€8.500 (-3.610%).

Currently there is a rather positive sentiment for Sartorius AG ST with 4 Buy predictions and 0 Sell predictions.

With a target price of 310 € there is a positive potential of 37.17% for Sartorius AG ST compared to the current price of 226.0 €.

Our community identified positive and negative aspects for Sartorius AG ST stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Sartorius AG ST stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.

Sartorius is a German-based biotech and laboratory equipment company that is listed on the Frankfurt Stock Exchange under the symbol SARTF. The company provides products and services for the pharmaceutical, biotech, and food industries, including laboratory instruments, consumables, and services. Sartorius has a global presence with operations in Europe, Asia, and the Americas, and has a strong reputation for innovation, quality, and reliability. The company's stock has performed well in recent years, reflecting its solid financial results and growth prospects in the life sciences industry.

Feedback

Pros and Cons of Sartorius AG ST in the next few years

Pros

G***** c******* t* c**********

M***** P*******

C******** o* t** e**********

Cons

S********** s********

W********* I********* f** t** n*** y****

B****

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of Sartorius AG ST vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
Sartorius AG ST
Sartorius AG VZO
Healthequity Inc.
Integer Hldg

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2023-04-20

Sartorius is an established player in the Healthcare Equipment & Supplies industry, and their financials reflect a strong position in the market. The company has displayed consistent growth in revenues, assets, and shareholder equity over the years. However, there are certain aspects of their financials that may warrant closer scrutiny.

Increasing Revenue: Sartorius has experienced consistent growth in its total revenue over the past three years, increasing from €2,335,657,000 in 2020 to €4,174,700,000 in 2022.

Growth in Total Assets: The company has reported a substantial increase in its total assets, which rose from €4,697,348,000 in 2020 to €6,977,700,000 in 2022. This demonstrates a strong financial position and the potential for further growth.

Feedback